ShawkiLotfiQasimMD
Pediatric Hematology & Oncology • Houston, TXAssistant Professor of Pediatric Hematology-Oncology
Dr. Qasim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1102 Bates Ave
Texas Childrens Hospital Feigin Tower Suite 1025
Houston, TX 77030Phone+1 832-824-4288Fax+1 832-825-1453
Summary
- -EMR Director for Texas Children’s Cancer and Hematology Centers.
-Chair of the Beacon Work Team
-Associate Director-Business Operations
Education & Training
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2015 - 2018
University of Iowa Hospitals and ClinicsResidency, Pediatrics, 2012 - 2015
University of Jordan Faculty of MedicineClass of 2010
Certifications & Licensure
TX State Medical License 2018 - 2025
IA State Medical License 2012 - 2017- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
- Epic SystemsProfessional Builder
Awards, Honors, & Recognition
- Fellow of the American Academy of Pediatrics American Academy of Pediatrics, 2012
Publications & Presentations
PubMed
- 15 citationsCOVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas.Kala Y. Kamdar, Taylor O Kim, Erin E Doherty, Thomas M Pfeiffer, Shawki L Qasim
Pediatric Hematology and Oncology. 2021-05-25 - 10 citationsp21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma.Shawki L Qasim, Laura Sierra, Ryan Shuck, Lyazat Kurenbekova, Tajhal Patel
Oncogene. 2021-01-07
Journal Articles
- COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, TexasKala Y Kamdar, Taylor O Kim, Erin E Doherty, Thomas M Pfeiffer, Shawki L Qasim, Mary Nell Suell, Amber M Yates, Susan M Blaney, Pediatric Hematology and Oncology, 5/25/2021
- p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcomaShawki Qasim, MD, Oncogene-Nature, 1/7/2021
Books/Book Chapters
Authored Content
- Background and Presentation of Autoimmune Hemolytic AnemiaMay 2018
Professional Memberships
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
